Landos Biopharma, Inc.

NASDAQ:LABP

22.93 (USD) • At close May 23, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Operating Activities:
Net Income -8.897-6.119-5.86-3.922-6.034-5.232-7.896-11.284-14.864-20.097-12.6044.097-9.818-11.341-8.23-4.777-5.796-3.508
Depreciation & Amortization 00.012000.0321.72700.2240.3530.0550.0480.050.0430.0350.0360.0370.0290.028
Deferred Income Tax 01.52100-1.521000000.8320.438-0.1781.0020000
Stock Based Compensation 0.260.2450.2480.2540.2240.1960.20.6340.9412.4280.3550.3121.0230.0390000
Change In Working Capital 0.1390.9053.387-1.457-2.3921.351-0.259-7.794-3.3725.798-0.3654.514-4.0561.8652.914-1.4412.5330.861
Accounts Receivables 000000000000000000
Change In Inventory 000000000000000000
Change In Accounts Payables 0.1870.2430.103-1.21-1.2650.289-1.507-5.171-3.0842.758-0.5622.489-0.4222.3272.448-1.0612.7920.365
Other Working Capital -0.0480.6623.284-0.2471.2651.0621.248-2.623-0.2883.040.1972.025-3.634-0.4620.466-0.38-0.2590.496
Other Non Cash Items 0.073-1.533-0.0030.0151.521-1.7410.3820.2230.44-0.241-0.11-0.0110.4260.009-0.0990.357-0.134-0.196
Operating Cash Flow -8.498-4.969-2.228-5.11-8.17-3.699-7.573-17.997-16.502-12.057-11.8449.4-12.56-8.391-5.379-5.824-3.368-2.815
Investing Activities:
Investments In Property Plant And Equipment 00000-0.007-0.138-0.035-0.0070.037-0.264-0.149-0.064-0.09-0.012-0.059-0.020.001
Acquisitions Net 000000.0630.1380.0350.242-0.114-0.12100.1120.0880000
Purchases Of Investments 00000-3.6720.001-2.645-1.027-8.939-80.505-4.03-81.379-7.295-4.331-8.841-1.251-40.319
Sales Maturities Of Investments 00.0630.6343.9743.10411.40817.07328.48120.5410.69891.64.8949.39514.3157.80710.932.9780.152
Other Investing Activites 0-0.0570003.6790.1380.035-0.2420.1140.1210-0.112-0.0880000
Investing Cash Flow 00.0630.6343.9743.10411.47117.21225.87119.5061.79610.8310.715-72.0486.933.4642.031.707-40.166
Financing Activities:
Debt Repayment 000000000000000000
Common Stock Issued 0-16.5670-0.09916.66600002.4940090.5061.5180000
Common Stock Repurchased 019.56700-30000000000000
Dividends Paid 000000000000000000
Other Financing Activities 0-4.8390000000-1.870.21900.25800000
Financing Cash Flow 0-1.8390-0.09913.66600000.6240.219090.7641.5180000
Other Information:
Effect Of Forex Changes On Cash 0.003-0.0030.0030.040.004-0.01200.079-0.0210.049000-0.1180.085000
Net Change In Cash -8.495-4.909-1.591-1.1958.6047.769.6397.9532.983-9.588-0.79410.1156.156-0.061-1.83-3.84-1.661-42.981
Cash At End Of Period 29.05437.54942.45844.04945.24436.6428.8819.24111.2888.30517.89318.6878.5722.4162.4774.3078.1479.808